mecamylamine has been researched along with Anorexia in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zarrindast, MR | 1 |
| Oveisi, MR | 1 |
1 other study available for mecamylamine and Anorexia
| Article | Year |
|---|---|
Effects of monoamine receptor antagonists on nicotine-induced hypophagia in the rat.
Topics: Adrenergic Antagonists; Animals; Anorexia; Atropine; Cholinergic Agents; Cholinergic Antagonists; Do | 1997 |